Queisser W, Heim M E
Onkologisches Zentrum, I. Medizinische Klinik, Fakultät für Klinische Medizin Mannheim, Universität Heidelberg.
Onkologie. 1989 Aug;12(4):156-60. doi: 10.1159/000216630.
The results of combined radiation and chemotherapy for the treatment of gastric carcinoma are reviewed. A small amount of postoperative adjuvant combined treatments of the curatively resected gastric carcinoma was performed which do not suggest any advantage of treatment compared to observation. For locally advanced and unresectable gastric carcinoma 5-fluorouracil or ftorafur was administered simultaneously to local irradiation in several phase-II studies. The response rates of 37%-58% and one year survival of 45%-72% do not suggest an advantage of combined modality compared to the one way treatment. The FAM, FAMe or FAB regimen was also used and obviously do not improve the results of combined modality treatment. A small but well conducted prospective randomized trials compared radiotherapy with and without chemotherapy or chemotherapy with and without radiotherapy. Recent results from different cooperative groups failed to improve the treatment results in terms of response and survival.
本文回顾了胃癌联合放疗与化疗的治疗结果。对根治性切除的胃癌进行了少量术后辅助联合治疗,但与观察相比,未显示出治疗有任何优势。在几项II期研究中,对于局部晚期和不可切除的胃癌,在局部放疗的同时给予5-氟尿嘧啶或替加氟。37%-58%的缓解率和45%-72%的一年生存率表明,与单一治疗相比,联合治疗并无优势。也使用了FAM、FAMe或FAB方案,但显然并未改善联合治疗的效果。一项规模较小但实施良好的前瞻性随机试验比较了放疗联合化疗与单纯放疗、化疗联合放疗与单纯化疗的效果。不同协作组的最新结果在缓解率和生存率方面均未改善治疗效果。